SCHEMBL24245609

SCHEMBL24245609

CCC(C)(C)c1nc(-c2cccc(-c3ccccc3)c2)c2c(n1)oc1ccccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.35
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ PLA2G2A P14555 3/20 0.34
▸ PLA2G4A P47712 3/20 0.34
▸ HPGD P15428 2/20 0.33
▸ LMNA P02545 1/20 0.33
▸ GAA P10253 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ PLA2G10 O15496 1/20 0.32
▸ L3MBTL1 Q9Y468 2/20 0.32
▸ CDK5 Q00535 1/20 0.32
▸ CDK5R1 Q15078 1/20 0.32
▸ PSMD14 O00487 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ RECQL P46063 1/20 0.32
▸ RAB9A P51151 1/20 0.31
▸ EGFR P00533 2/20 0.31
▸ IGF1R P08069 2/20 0.31
▸ FLT4 P35916 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23920437 0.92 ALDH1A1 (0.37) ALDH1A1SMN1; SMN2HPGDLMNAHSD17B10
SCHEMBL23473799 0.89 PLA2G2A (0.37) ALDH1A1SMN1; SMN2PLA2G2APLA2G4AHPGD
SCHEMBL19162692 0.80 MEN1 (0.40) ALDH1A1SMN1; SMN2PLA2G2APLA2G4AHPGD
SCHEMBL19161626 0.80 MEN1 (0.42) ALDH1A1SMN1; SMN2HPGDLMNAGAA
SCHEMBL16902567 0.78 PLA2G2A (0.40) ALDH1A1SMN1; SMN2PLA2G2APLA2G4AHPGD
SCHEMBL18370631 0.78 PLA2G2A (0.40) ALDH1A1SMN1; SMN2PLA2G2APLA2G4AHPGD
SCHEMBL18017717 0.78 PLA2G2A (0.40) ALDH1A1SMN1; SMN2PLA2G2APLA2G4AHPGD
SCHEMBL18370621 0.78 PLA2G2A (0.40) ALDH1A1SMN1; SMN2PLA2G2APLA2G4AHPGD
SCHEMBL16902562 0.78 MEN1 (0.40) ALDH1A1SMN1; SMN2PLA2G2APLA2G4AHPGD
SCHEMBL18017690 0.78 PLA2G2A (0.40) ALDH1A1SMN1; SMN2PLA2G2APLA2G4AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220045281-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2022-02-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220045281-A1 ORGANIC ELECTROLUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME ELAVL1, ICOSLG, OR10J3 ALDH1A1 784/4885SMN1; SMN2 729/4885PLA2G2A 3018/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback